Pharmaclone

Pharmaclone is a Russian biotechnology company specializing in the development and production of monoclonal antibodies and recombinant proteins. Founded in 1992 and based in Moscow, the company utilizes a proprietary hybridoma-based platform to create therapeutic agents for a variety of medical conditions, including urological, gastrointestinal, and neurological disorders. Pharmaclone is particularly known for its collaboration with Materia Medica Holding, where it provides the R&D and manufacturing expertise for antibody-based drugs. Its commercial portfolio includes products such as Afalaza, Impaza, and Kolofort, which are widely distributed in the Russian and CIS markets. The company maintains integrated facilities for the full cycle of drug development, from initial antigen design to large-scale production.